BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 905 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,273 | -62.0% | 516,377 | -51.4% | 0.02% | -61.7% |
| Q1 2024 | $45,443 | +29.6% | 1,063,251 | +17.3% | 0.06% | +22.4% |
| Q4 2023 | $35,054 | +11.8% | 906,732 | +9.2% | 0.05% | +8.9% |
| Q3 2023 | $31,351 | -53.6% | 830,719 | -43.9% | 0.04% | -47.7% |
| Q2 2023 | $67,517 | +39.0% | 1,481,945 | +23.8% | 0.09% | +32.3% |
| Q1 2023 | $48,565 | -37.1% | 1,197,354 | -20.9% | 0.06% | -38.7% |
| Q4 2022 | $77,174 | -99.9% | 1,514,099 | -17.2% | 0.11% | -25.9% |
| Q3 2022 | $98,481,000 | -21.5% | 1,828,456 | -6.4% | 0.14% | -12.8% |
| Q2 2022 | $125,432,000 | -30.1% | 1,952,855 | -15.6% | 0.16% | -14.6% |
| Q1 2022 | $179,486,000 | -22.0% | 2,314,753 | -13.7% | 0.19% | -16.9% |
| Q4 2021 | $230,110,000 | +6.1% | 2,680,686 | -0.6% | 0.23% | 0.0% |
| Q3 2021 | $216,957,000 | -1.6% | 2,697,462 | -1.5% | 0.23% | +1.3% |
| Q2 2021 | $220,507,000 | -5.0% | 2,739,217 | -0.4% | 0.23% | -11.3% |
| Q1 2021 | $232,001,000 | +15.4% | 2,750,786 | +9.8% | 0.26% | +14.7% |
| Q4 2020 | $201,046,000 | +18.8% | 2,505,563 | +19.1% | 0.22% | +8.2% |
| Q3 2020 | $169,202,000 | -5.1% | 2,103,977 | +1.6% | 0.21% | -8.8% |
| Q2 2020 | $178,235,000 | +7.5% | 2,070,097 | +1.4% | 0.23% | -9.2% |
| Q1 2020 | $165,735,000 | +12.2% | 2,041,324 | +15.5% | 0.25% | +42.0% |
| Q4 2019 | $147,770,000 | +37.0% | 1,767,166 | +43.3% | 0.18% | +29.4% |
| Q3 2019 | $107,843,000 | +5.5% | 1,232,910 | -1.2% | 0.14% | +6.2% |
| Q2 2019 | $102,251,000 | -4.3% | 1,248,485 | -5.0% | 0.13% | -6.6% |
| Q1 2019 | $106,820,000 | +17.3% | 1,313,735 | -5.1% | 0.14% | +3.8% |
| Q4 2018 | $91,078,000 | -23.2% | 1,383,738 | -10.1% | 0.13% | -5.7% |
| Q3 2018 | $118,611,000 | +2.8% | 1,538,605 | -1.5% | 0.14% | -2.8% |
| Q2 2018 | $115,335,000 | +10.1% | 1,561,962 | -3.0% | 0.14% | +10.8% |
| Q1 2018 | $104,718,000 | -1.8% | 1,610,062 | -2.4% | 0.13% | +1.6% |
| Q4 2017 | $106,666,000 | +3.0% | 1,650,162 | -0.0% | 0.13% | -3.0% |
| Q3 2017 | $103,566,000 | -6.5% | 1,650,462 | -9.8% | 0.13% | -9.6% |
| Q2 2017 | $110,820,000 | +38.9% | 1,830,523 | +19.0% | 0.15% | +35.2% |
| Q1 2017 | $79,801,000 | +16.2% | 1,538,771 | -0.6% | 0.11% | +11.3% |
| Q4 2016 | $68,669,000 | -6.1% | 1,548,698 | +0.8% | 0.10% | -7.6% |
| Q3 2016 | $73,109,000 | +1.3% | 1,535,900 | -3.8% | 0.10% | 0.0% |
| Q2 2016 | $72,167,000 | +6.1% | 1,595,900 | -3.6% | 0.10% | +1.0% |
| Q1 2016 | $68,023,000 | +15.7% | 1,655,875 | +7.4% | 0.10% | +15.6% |
| Q4 2015 | $58,804,000 | +23.0% | 1,541,400 | +5.9% | 0.09% | +18.4% |
| Q3 2015 | $47,810,000 | -53.0% | 1,455,400 | 0.0% | 0.08% | -49.0% |
| Q2 2015 | $101,776,000 | +0.2% | 1,455,400 | -1.8% | 0.15% | +0.7% |
| Q1 2015 | $101,543,000 | -6.9% | 1,482,385 | -0.4% | 0.15% | -8.6% |
| Q4 2014 | $109,113,000 | -0.6% | 1,488,778 | -2.7% | 0.16% | -1.2% |
| Q3 2014 | $109,773,000 | -1.4% | 1,529,511 | -0.7% | 0.16% | -0.6% |
| Q2 2014 | $111,370,000 | -1.7% | 1,540,385 | 0.0% | 0.16% | -5.7% |
| Q1 2014 | $113,342,000 | +5.8% | 1,540,385 | 0.0% | 0.18% | +4.2% |
| Q4 2013 | $107,134,000 | +2.7% | 1,540,385 | -3.0% | 0.17% | -4.5% |
| Q3 2013 | $104,269,000 | -10.6% | 1,587,285 | -5.8% | 0.18% | -14.1% |
| Q2 2013 | $116,684,000 | – | 1,684,475 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 53,850,000 | $2,054,378,000 | 20.84% |
| Smithwood Advisers, L.P. | 1,000,000 | $38,150,000 | 10.54% |
| SECTOR GAMMA AS | 937,600 | $35,769,000 | 9.19% |
| Smithwood Advisers, L.P. | 500,000 | $19,075,000 | 5.27% |
| Veritas Asset Management LLP | 10,592,749 | $404,113,000 | 5.07% |
| York Capital Management Global Advisors, LLC | 7,887,822 | $300,921,000 | 4.47% |
| Iguana Healthcare Management, LLC | 325,000 | $12,399,000 | 4.08% |
| Osher Van de Voorde Investment Management | 174,160 | $6,644,000 | 3.82% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $7,630,000 | 3.22% |
| Governors Lane LP | 600,000 | $22,890,000 | 3.22% |